For the Inventor, By the Inventor

Enter assignee name

Chicago, IL, United States of America

Biovec, LLC

USPTO Granted Patents = 14

% Expired Patents = 100.0

EPO Patents = 1

Forward Citations = 46

Loading Chart...

Loading Chart...

2 inventors (with patents filed for the assignee):

Lakshman R Sehgal (14 out of 27 patents)

Jonathan Wong (14 out of 14 patents)

14 patents: Sort by Forward Citations

1. 9388427 - In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors (2016-07-12),

2. 9353383 - Vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors (2016-05-31),

3. 8420075 - Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases (2013-04-16),

4. 8367056 - In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors (2013-02-05),

5. 8242095 - In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors (2012-08-14),

6. 8236300 - In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors (2012-08-07),

7. 8048410 - In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors (2011-11-01),

8. 7803365 - Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases (2010-09-28),

9. 7713522 - Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases (2010-05-11),

10. 7687058 - Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases (2010-03-30),

11. 7670597 - Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases (2010-03-02),

12. 7501114 - Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases (2009-03-10),

13. 7481998 - Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases (2009-01-27),

14. 7179459 - [object Object] (2007-02-20),

BIOVEC, LLC is a leading biotechnology company specializing in the development of innovative vector-based solutions. With a strong focus on bioengineering, our team of expert scientists and researchers strive to create novel vectors for gene therapy, drug delivery, and biopharmaceutical production. Our cutting-edge technology and commitment to excellence have positioned us at the forefront of the industry, enabling us to deliver groundbreaking solutions that address critical challenges in healthcare and biotechnology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

14 Patents

#274 in Chicago, IL

#1,121 in Illinois

#22,261 in US

#42,111 in the World

Chicago, IL, United States of America

Biovec, LLC

Forward Citations = 46

2 inventors:

Lakshman R Sehgal (14 out of 27 patents)

Jonathan Wong (14 out of 14 patents)

Please report any incorrect information to [email protected]

Loading…